Secretory leukocyte protease inhibitor (SLPI) attenuates TLR4/NF-κB-mediated neuroinflammation in amyotrophic lateral sclerosis: a candidate molecule associated with neuro-pathology

Molecular Medicine · Published 2026-07-17 · DOI 10.1186/s10020-026-01572-8

Free full text

Authors (10)

Ming-An Li, Yi-Zhi Song, Ting Li, Jian Wu, Yue Tao, Rui Hu, Chen-Meng Qiao, Chun Cui, Wei-Jiang Zhao, Yan-Qin Shen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Li, M., Song, Y., Li, T., et al. (2026). Secretory leukocyte protease inhibitor (SLPI) attenuates TLR4/NF-κB-mediated neuroinflammation in amyotrophic lateral sclerosis: a candidate molecule associated with neuro-pathology. Molecular Medicine. https://doi.org/10.1186/s10020-026-01572-8

Related articles